Understanding the Growth of the Progressive Familial Intrahepatic Cholestasis Market (2025-2035)
According to the IMARC Group, the progressive familial intrahepatic cholestasis market is projected at a CAGR of 4.75% during 2025-2035. This can be attributed to numerous key players making extensive investments in research initiatives to investigate the utilization of gene therapy catering to the underlying genetic mutations that cause the disease. Progressive familial intrahepatic cholestasis (PFIC) is a rare…
robertsmith0252
Rapid Growth: Polymyalgia Rheumatica Market Set to Expand at 13.06% CAGR Through 2034
According to the IMARC Group, the polymyalgia rheumatica market exhibited a market size of US$ 3,287.1 Million in the year 2023 and is projected at a CAGR of 13.06 % during 2024-2034. This can be attributed to the increasing use of subcutaneous sarilumab injection in disease medication since it works by inhibiting the interleukin-6 activity, a substance that…